Latest news
News
Autobiographical ‘life story’ books used to support dementia and stroke patients who struggle to communicate
Dementia patients and those who struggle to communicate after a stroke have been supported to create…
Arts and Health
Exhibition by local school pupils goes on display at the RAH
Artwork created by Renfrewshire school children has gone on display to staff and visitors at the Roy…
News
£6670 gesture of thanks for NHSGGC staff who cared for dad after horror incident
A dad-of-two who spent 16 weeks in hospital after a horrific incident left him fighting for his life…
Additional news resources
Contacts for media and journalist enquiries only!
News on social media
Facebook Posts
👁️ Eye problem? If your eyes are sore, red or itchy, the best first stop is your local optometrist, not your GP. ![]()
![]()
You don’t need to be a glasses wearer to get help, and appointments are NHS‑covered for clinical eye assessments.![]()
![]()
Find out more about how Optometrists can help you: www.nhsggc.scot/your-health/right-care-right-place/faces-of-primary-care/willis-wilkie-optometrist/
Patient John MacDonald has become the first person in the world to undergo a clinical trial that aims to improve outcomes for those having specialist heart surgery. John volunteered to take part in the PROTECT study, which uses gene therapy during Coronary Artery Bypass Graft Surgery to help prevent thickening and blockage of the graft over time – potentially prolonging its effectiveness and reducing graft failure.![]()
![]()
John received the treatment at Golden Jubilee University National Hospital after he suffered a heart attack at home at the beginning of August 2025. He said: “I’m glad to be helping the clinical and research teams achieve what they are trying to do, and I’d encourage others to consider taking part in studies like this one that could help many people in the future. We as a family are forever grateful to a magnificent team of surgeons, doctors and nurses who have fixed my failing heart and given me my quality of life back.”![]()
![]()
The PROTECT study is sponsored by NHS Greater Glasgow and Clyde’s Research and Innovation directorate in partnership with the University of Glasgow and in collaboration with NHS Golden Jubilee and the University of Edinburgh and marks a major milestone in cardiovascular research. The clinical trial is supported by the Medical Research Council and British Heart Foundation, and has received additional support from the Cell and Gene Therapy Catapult, MVLS Translational Research Initiatives Wellcome Translational Partnership Award and Northern Alliance Advanced Therapy Treatment Centre, as well as the universities of Bristol and Cardiff.![]()
![]()
Read more: www.nhsggc.scot/scottish-patient-becomes-first-to-take-part-in-groundbreaking-cardiac-gene-therap…
Was this helpful?
Thanks for your feedback!